Neonatal morbidity and mortality are important public health indicators used to monitor and evaluate neonatal health and quality of perinatal care. 1,2 The neonatal period, ranging from birth to 27 days thereafter, is the most vulnerable time for infant survival. 1 Around 75% of infant deaths occur during this period, largely from prematurity and other conditions that can often be prevented by timely obstetrical and neonatal care. 3,4 In high-income countries, improvements in health care have resulted in a decline in neonatal mortality, 5,6 including in Canada, where the rate is 3.6 deaths per 1000 live births. 7 Accordingly, research and public health surveillance has increasingly focused on severe neonatal morbidity (SNM), which refers to a newborn who has survived a severe complication during birth or the neonatal period. 1,8,9 Identifying newborns at high risk of SNM is crucial as it has serious implications for the surviving child and their family. 10,11 Limited research has examined SNM in high-income countries. 2,6,8,[12][13][14][15][16][17] Studies have primarily focused on deriving and validating the criteria to define SNM, 1,3,10 quantifying the prevalence of SNM and identifying risk factors in African, Asian and Latin American regions. 11,[18][19][20][21][22][23][24][25][26][27] Research is also lacking on a range of upstream social determinants of health inequity and their influence on SNM. 28,29 Living in a low-income area 12,[30][31][32][33][34][35] and being an